プレベナーの日本における特別使用効果調査（規制当局による市販後調査計画）

基本情報

NCT ID

NCT01521897

ステータス

完了

試験のフェーズ

-

試験タイプ

観察

目標被験者数

1,143

治験依頼者名

Pfizer

概要

This surveillance aims to figure out 1) use-results, 2) occurrence of adverse events, and 3) factors affecting safety in terms of the safety in infants starting to receive Prevenar at the age of more than 2 and less than 7 months in routine medical practice. This surveillance will specifically focus on the occurrence of the following: 1. Local reactions at the injection site 2. Systemic reactions for each concomitant vaccine (especially fever more than 39C°)

対象疾患

介入

依頼者（Sponsor）

実施施設 (1)